Δ
We will be in touch with you shortly.
For decades, most cosmetic products were developed by combining well-known ingredients into new textures, fragrances and formats. That is changing. A growing number of beauty companies now develop products the way pharmaceutical companies develop drugs: starting from a biological target, screening candidates systematically, testing in validated models, and proving efficacy in clinical studies.
The shift is driven by consumers who expect visible, proven results, by the rise of dermocosmetics and “skin health” positioning, and by tighter regulation of both safety and claims.
The trend spans the whole industry. Large beauty groups run dermatology-focused brands and use reconstructed human skin models in their research. Ingredient suppliers increasingly launch biotech actives, such as peptides, ferments and bio-identical molecules, with clinical data attached. And fast-growing direct-to-consumer brands have built their own biotech labs, using AI-driven screening, in vitro and ex vivo testing, and human clinical studies to develop proprietary molecules.
Pharmaceutical development works because every result is recorded, traceable and connected: which batch, which formula, which method, which conditions. Many cosmetics labs are not built that way. Formulas live in spreadsheets, stability data in separate files, clinical results in reports, and safety documents in shared folders.
That is manageable when products are simple. It breaks down when a brand develops its own actives, runs clinical studies and has to defend every claim. Typical problems include:
Scieline brings the discipline of pharmaceutical development to cosmetics and personal care R&D. It connects formula management with INCI-based raw materials, stability and compatibility studies, preservative efficacy, safety, sensory and clinical results in one platform, with full traceability from raw material lot to finished product. The Scieline Assistant lets teams ask questions about past work in plain language, grounded in their own data, patents and literature. And because Scieline runs on-premise or in a private cloud, proprietary actives and formulation know-how stay inside the company.
Pharma-style methods are raising the bar for what a cosmetic product can prove. The companies that keep their development data just as rigorous will be the ones that bring those products to market fastest.
Beauty brands are adopting the methods of pharmaceutical development: targeted actives, validated mo…
Many scale-up problems start with details that were never written down at the bench. Here is what fo…
Stability studies are among the most expensive data a formulation lab produces. Most of it is used o…
Discontinued, restricted or expensive ingredients force formulators to reformulate. With the right d…
Contact Us today or Request a Demo to see Scieline in action.